Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 29 citing Hopley: Cost utility of screening and treatment for early age related macular degeneration.... (0.10 sec) 

The epidemiology of age-related macular degeneration


JM Seddon, CA Chen - International ophthalmology clinics, 2004 - journals.lww.com
Age-related macular degeneration (AMD) is the leading cause of irreversible
blindness.1,2 Because AMD adversely affects activities of daily living,
rendering it more difficult to read, write, and drive, many affected ...
Cited by 105 - Related articles - BL Direct - All 3 versions

Cost utility of photodynamic therapy for predominantly classic neovascular age related …


C Hopley, G Salkeld, P Mitchell - British journal of ophthalmology, 2004 - bjo.bmj.com
Methods: Cost utility analysis (CUA) was conducted to estimate the cost
effectiveness of PDT for scenarios involving reasonable (6/12) and poor (6/60)
visual acuity. The models incorporated data from the Treatment of ...
Cited by 38 - Related articles - BL Direct - All 8 versions

Treatment of age-related macular degeneration


GW Bylsma, RH Guymer - Clin Exp Optom, 2005 - grande.nal.usda.gov
Title: Treatment of age-related macular degeneration. Author: Bylsma,-GW;
Guymer,-RH Citation: Clin-Exp-Optom. 2005 Sep; 88(5): 322-34 Abstract:
Age-related macular degeneration (AMD) is the greatest cause of legal ...
Cited by 21 - Related articles - Cached - All 5 versions

Cost-effectiveness of vitamin therapy for age-related macular degeneration

- v2020la.org [PDF] 
DB Rein, JB Saaddine, JS Wittenborn, KE … - Ophthalmology, 2007 - Elsevier
Cited by 12 - Related articles - All 32 versions

Awareness of and compliance with recommended dietary supplement among age-related …


WTN MPHTM, MG FRANZCO - Clinical & Experimental Ophthalmology - interscience.wiley.com
It is also possible that your web browser is not configured or not able to
display style sheets. In this case, although the visual presentation will be
degraded, the site should continue to be functional. We recommend using the ...
Cited by 10 - Related articles - BL Direct - All 5 versions

Value-based medicine and interventions for macular degeneration

- prsjournal.com
MM Brown, GC Brown, H Brown - Current Opinion in Ophthalmology, 2007 - journals.lww.com
Purpose of review The aim of this article is to review the patient value
conferred by interventions for neovascular macular degeneration. Recent findings
Value-based medicine is the practice of medicine based upon the patient ...
Cited by 9 - Related articles - BL Direct - All 4 versions

The burden of age-related macular degeneration

- adisonline.com [PDF] 
JK Schmier, ML Jones, MT Halpern - Pharmacoeconomics, 2006 - ingentaconnect.com
As age-related macular degeneration (AMD) becomes more prevalent as a Abstract
result of longer life expectancy and the number of elderly people worldwide, it
will become increasingly important to understand its potential health and ...
Cited by 9 - Related articles - BL Direct - All 7 versions

Delay in treating age-related macular degeneration in Spain is associated with progressive …


L Arias, F Armadá, J Donate, J García-Arumí, … - Eye, 2008 - nature.com
Median time from the diagnosis to treatment visit was 2.3 months (95% confidence
interval: 0.2–10.8 months). Vision loss had progressed at the treatment visit
with a doubling in the percentage of patients with a visual acuity of ...
Cited by 8 - Related articles - All 3 versions

Assessment of age-related maculopathy using subjective vision tests

- qut.edu.au [PDF] 
JE Lovie-Kitchin, B Feigl, 2008 - eprints.qut.edu.au
A paper published by the first author in this journal almost 25 years ago 1 on
the assessment of 'senile macular degenera- tion' reviewed the standard tests of
clini- cal vision according to three criteria: 1. Were the tests effective ...
Cited by 7 - Related articles - All 5 versions

Treatments for choroidal and retinal neovascularization: a focus on oligonucleotide therapy …


RJM PhD, PER PhD - Clinical & experimental ophthalmology - interscience.wiley.com
Blinding eye diseases caused by neovascularization of the retinal tissue are the
leading cause of blindness in Western societies. Current treatments, such as
laser photocoagulation, are limited in their effectiveness at halting the ...
Cited by 5 - Related articles - All 4 versions


Result Page: 

1

2

3

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google